The fixed-dose approach, particularly the high dose of oral semaglutide may not sound practical especially in daily clinical practice
One drawback associated with GLP-1 medications is that weight loss not only includes fat loss, but muscle loss as well
Urgent neurological evaluation is needed for new focal weakness, foot drop, bowel or bladder dysfunction, or rapidly progressive symptoms
Based on data from a 2026 clinical trial, the Wegovy pill appears to be slightly more effective for weight loss than Foundayo
[4] In endurance, oral L-glutamine helps maintain gastrointestinal barrier integrity and reduces exercise-induced damage markerssupporting recovery and exercise readiness
This mechanism is likely crucial for mediating liraglutide-induced weight loss (Secher et al 2014)